SCHEMBL1259372

SCHEMBL1259372

COCC(CN)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GABBR2 O75899 2/20 0.50
GABBR1 Q9UBS5 2/20 0.50
TAAR1 Q96RJ0 4/20 0.48
HTR2A P28223 2/20 0.48
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
PKM P14618 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
CHRNB2 P17787 1/20 0.41
CHRNA4 P43681 1/20 0.41
HRH1 P35367 1/20 0.40
ALDH1A1 P00352 1/20 0.40
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
SLC6A3 Q01959 1/20 0.38
SCN4A P35499 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL813771 0.87 CYP1A2 (0.50) TAAR1HTR2ACYP1A2CYP2D6PKM
SCHEMBL12824731 0.84 ALDH1A1 (0.53) GABBR2GABBR1TAAR1HTR2ACYP1A2
SCHEMBL9246055 0.83 CYP1A2 (0.42) HTR2ACYP1A2CYP2D6PKMSMN1; SMN2
SCHEMBL1169267 0.83 CYP1A2 (0.42) HTR2ACYP1A2CYP2D6PKMSMN1; SMN2
SCHEMBL4476581 0.81 LMNA (0.45) TAAR1HTR2ACYP1A2CYP2D6PKM
SCHEMBL12819487 0.81 LMNA (0.45) TAAR1HTR2ACYP1A2CYP2D6PKM
SCHEMBL11992984 0.81 LMNA (0.45) TAAR1HTR2ACYP1A2CYP2D6PKM
SCHEMBL14453825 0.80 TAAR1 (0.50) GABBR2GABBR1TAAR1HTR2ACYP1A2
SCHEMBL14791784 0.80 GABBR2 (0.47) GABBR2GABBR1TAAR1HTR2ACYP1A2
SCHEMBL1539105 0.79 TAAR1 (0.65) GABBR2GABBR1TAAR1HTR2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1590666-A4 COMPOSITIONS AND METHODS FOR ENHANCING APOPTOSIS GENENTECH INC (US) 2006-07-26 EP claimed
EP-1590666-A1 COMPOSITIONS AND METHODS FOR ENHANCING APOPTOSIS Genentech, Inc. (US) 2005-11-02 EP claimed
WO-2004072641-A1 COMPOSITIONS AND METHODS FOR ENHANCING APOPTOSIS GENENTECH, INC. (US) 2004-08-26 WO claimed
US-9346805-B2 Pyrimidyl cyclopentanes as Akt protein kinase inhibitors ARRAY BIOPHARMA INC. (US) 2016-05-24 US disclosed
US-20110039324-A1 COMPOSITIONS AND METHODS FOR ENHANCING APOPTOSIS GENENTECH, INC. (US) 2011-02-17 US disclosed
WO-2003014113-A1 NOVEL BENZOPYRAN COMPOUNDS AND PROCESS FOR THEIR PREPARATION AND USE GLENMARK PHARMACEUTICALS LIMITED (IN) 2003-02-20 WO disclosed